DE10123163A1
(en)
*
|
2001-05-09 |
2003-01-16 |
Gruenenthal Gmbh |
Substituted cyclohexane-1,4-diamine derivatives
|
ES2296962T3
(en)
|
2001-06-27 |
2008-05-01 |
Smithkline Beecham Corporation |
PIRROLIDINS AS INHIBITORS OF DIPEPTIDIL PEPTIDASA.
|
EP1399433B1
(en)
|
2001-06-27 |
2007-08-22 |
Smithkline Beecham Corporation |
Fluoropyrrolidines as dipeptidyl peptidase inhibitors
|
ATE455759T1
(en)
|
2001-06-27 |
2010-02-15 |
Smithkline Beecham Corp |
FLUOROPYRROLIDINE AS A DIPEPTIDYLPEPTIDASE INHIBITOR
|
US6861440B2
(en)
*
|
2001-10-26 |
2005-03-01 |
Hoffmann-La Roche Inc. |
DPP IV inhibitors
|
DE60304911D1
(en)
|
2002-02-25 |
2006-06-08 |
Eisai Co Ltd |
Xanthine derivatives as DPP-IV inhibitors
|
EA007434B1
(en)
*
|
2002-02-28 |
2006-10-27 |
Прозидион Лимитед |
Glutaminyl based dpiv inhibitors
|
HUP0200849A2
(en)
*
|
2002-03-06 |
2004-08-30 |
Sanofi-Synthelabo |
N-aminoacetyl-pyrrolidine-2-carbonitrile derivatives, pharmaceutical compositions containing them and process for producing them
|
DE10213051B4
(en)
|
2002-03-23 |
2013-03-07 |
Grünenthal GmbH |
Substituted 4-aminocyclohexanols
|
HUP0202001A2
(en)
*
|
2002-06-14 |
2005-08-29 |
Sanofi-Aventis |
Azabicyclo-octane and nonane derivatives with ddp-iv inhibiting activity
|
JPWO2004007446A1
(en)
*
|
2002-07-10 |
2005-11-10 |
アステラス製薬株式会社 |
Novel azetidine derivative or salt thereof
|
TW200401635A
(en)
|
2002-07-23 |
2004-02-01 |
Yamanouchi Pharma Co Ltd |
2-Cyano-4-fluoropyrrolidine derivative or salt thereof
|
US7238724B2
(en)
|
2002-09-19 |
2007-07-03 |
Abbott Laboratories |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
|
US7262207B2
(en)
|
2002-09-19 |
2007-08-28 |
Abbott Laboratories |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
|
EP1556040A1
(en)
*
|
2002-10-24 |
2005-07-27 |
Sterix Limited |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2
|
GB0224830D0
(en)
|
2002-10-24 |
2002-12-04 |
Sterix Ltd |
Compound
|
DE10252666A1
(en)
|
2002-11-11 |
2004-08-05 |
Grünenthal GmbH |
N-piperidyl-cyclohexane derivatives
|
US7687625B2
(en)
*
|
2003-03-25 |
2010-03-30 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
CN100451004C
(en)
*
|
2003-03-31 |
2009-01-14 |
大正制药株式会社 |
Novel quinoline,Tetrahydroquinazoline,And pyrimidine derivatives and methods of treatment related to the use thereof
|
US20050197350A1
(en)
*
|
2003-03-31 |
2005-09-08 |
Taisho Pharmaceutical Co., Ltd. |
Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof
|
US20090137658A1
(en)
*
|
2003-05-06 |
2009-05-28 |
Tanabe Seiyaku Co.,Ltd. |
Benzenesulfonic acid salt compounds
|
GB0310593D0
(en)
*
|
2003-05-08 |
2003-06-11 |
Leuven K U Res & Dev |
Peptidic prodrugs
|
BRPI0411713B8
(en)
|
2003-06-20 |
2021-05-25 |
Hoffmann La Roche |
compounds, process for their manufacture, pharmaceutical compositions comprising them, method for treatment and/or prophylaxis of diseases that are associated with dpp-iv and their use
|
AU2004251829B2
(en)
|
2003-06-20 |
2009-12-17 |
F. Hoffmann-La Roche Ag |
Hexahydropyridoisoqinolines as DPP-IV inhibitors
|
EP1506967B1
(en)
*
|
2003-08-13 |
2007-11-21 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
US7678909B1
(en)
|
2003-08-13 |
2010-03-16 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
US7169926B1
(en)
|
2003-08-13 |
2007-01-30 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
HU227684B1
(en)
*
|
2003-08-29 |
2011-11-28 |
Sanofi Aventis |
Adamantane and azabicyclo-octane and nonane derivatives and their use as dpp-iv inhibitors
|
US7205409B2
(en)
|
2003-09-04 |
2007-04-17 |
Abbott Laboratories |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
|
JP2007505121A
(en)
*
|
2003-09-08 |
2007-03-08 |
武田薬品工業株式会社 |
Dipeptidyl peptidase inhibitor
|
WO2005030751A2
(en)
*
|
2003-09-08 |
2005-04-07 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
US7291744B2
(en)
|
2003-11-13 |
2007-11-06 |
Bristol-Myers Squibb Company |
N-ureidoalkyl-amino compounds as modulators of chemokine receptor activity
|
CA2545641A1
(en)
|
2003-11-17 |
2005-06-02 |
Novartis Ag |
Use of organic compounds
|
US7504423B2
(en)
|
2003-12-11 |
2009-03-17 |
Mitsubishi Tanabe Pharma Corporation |
α-amino acid derivatives and use thereof as medicines
|
AU2004298453A1
(en)
*
|
2003-12-19 |
2005-06-30 |
Altana Pharma Ag |
Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives
|
LT3366283T
(en)
|
2004-01-20 |
2021-12-10 |
Novartis Ag |
Direct compression formulation and process
|
KR101130433B1
(en)
*
|
2004-02-05 |
2012-03-27 |
교린 세이야꾸 가부시키 가이샤 |
Bicycloester derivative
|
EA009902B1
(en)
|
2004-02-13 |
2008-04-28 |
УОРНЕР-ЛАМБЕРТ КОМПАНИ Эл-Эл-Си |
Androgen receptor modulators
|
CN1922139B
(en)
*
|
2004-02-18 |
2010-12-29 |
杏林制药株式会社 |
Bicyclic amide derivatives
|
WO2005082847A1
(en)
*
|
2004-02-27 |
2005-09-09 |
Kyorin Pharmaceutical Co., Ltd. |
Bicyclo derivative
|
US7348346B2
(en)
|
2004-03-08 |
2008-03-25 |
Abbott Laboratories |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
|
US7732446B1
(en)
|
2004-03-11 |
2010-06-08 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
CN102134229B
(en)
*
|
2004-03-15 |
2020-08-04 |
武田药品工业株式会社 |
Dipeptidyl peptidase inhibitors
|
WO2005095357A2
(en)
*
|
2004-03-30 |
2005-10-13 |
Taisho Pharmaceutical Co., Ltd. |
Pyrimidine derivatives and methods of treatment related to the use thereof
|
BRPI0509759A
(en)
|
2004-04-13 |
2007-10-16 |
Warner Lambert Co |
androgen modulators
|
JP2007533726A
(en)
|
2004-04-22 |
2007-11-22 |
ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー |
Androgen modulator
|
TW200604167A
(en)
*
|
2004-04-27 |
2006-02-01 |
Astellas Pharma Inc |
Pyrrolidine derivatives
|
DE102004023635A1
(en)
|
2004-05-10 |
2006-04-13 |
Grünenthal GmbH |
Heteroaryl-substituted cyclohexyl-1,4-diamine derivatives
|
DE102004023507A1
(en)
|
2004-05-10 |
2005-12-01 |
Grünenthal GmbH |
Substituted cyclohexylacetic acid derivatives
|
DE102004023632A1
(en)
*
|
2004-05-10 |
2005-12-08 |
Grünenthal GmbH |
Substituted cyclohexylcarboxylic acid derivatives
|
WO2005118555A1
(en)
*
|
2004-06-04 |
2005-12-15 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
JP4874965B2
(en)
*
|
2004-07-08 |
2012-02-15 |
ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー |
Androgen regulator
|
WO2006019965A2
(en)
|
2004-07-16 |
2006-02-23 |
Takeda San Diego, Inc. |
Dipeptidyl peptidase inhibitors
|
WO2006011035A1
(en)
*
|
2004-07-23 |
2006-02-02 |
Glenmark Pharmaceuticals Ltd. |
Novel dipeptidyl peptidase iv inhibitors; process for their preparation and compositions containing them
|
WO2006012441A1
(en)
*
|
2004-07-23 |
2006-02-02 |
Susan Marie Royalty |
Peptidase inhibitors
|
US7842707B2
(en)
*
|
2004-07-23 |
2010-11-30 |
Nuada, Llc |
Peptidase inhibitors
|
JP2008514546A
(en)
*
|
2004-09-30 |
2008-05-08 |
大正製薬株式会社 |
Pyridine derivatives and therapies associated with their use
|
EP1799639B1
(en)
|
2004-10-12 |
2013-09-04 |
Glenmark Pharmaceuticals S.A. |
Novel dipeptidyl peptidase iv inhibitors, pharmaceutical compositions containing them, and process for their preparation
|
CN101087757B
(en)
*
|
2004-10-12 |
2013-01-02 |
格兰马克药品股份有限公司 |
Novel dipeptidyl peptidase iv inhibitors, process for their preparation and compositions containing them
|
EP1828192B1
(en)
*
|
2004-12-21 |
2014-12-03 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
DOP2006000008A
(en)
|
2005-01-10 |
2006-08-31 |
Arena Pharm Inc |
COMBINED THERAPY FOR THE TREATMENT OF DIABETES AND RELATED AFFECTIONS AND FOR THE TREATMENT OF AFFECTIONS THAT IMPROVE THROUGH AN INCREASE IN THE BLOOD CONCENTRATION OF GLP-1
|
EP1879881A2
(en)
*
|
2005-04-14 |
2008-01-23 |
Bristol-Myers Squibb Company |
Inhibitors of 11-beta hydroxysteroid dehydrogenase type i
|
US7553861B2
(en)
*
|
2005-04-22 |
2009-06-30 |
Alantos Pharmaceuticals Holding, Inc. |
Dipeptidyl peptidase-IV inhibitors
|
TW200724139A
(en)
|
2005-05-05 |
2007-07-01 |
Warner Lambert Co |
Androgen modulators
|
US7521557B2
(en)
*
|
2005-05-20 |
2009-04-21 |
Bristol-Myers Squibb Company |
Pyrrolopyridine-based inhibitors of dipeptidyl peptidase IV and methods
|
JP2008542901A
(en)
*
|
2005-05-31 |
2008-11-27 |
コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ |
Portable storage medium, host device, and method of accessing contents of portable storage medium by host device
|
ATE550031T1
(en)
|
2005-06-06 |
2012-04-15 |
Univ Georgetown |
COMPOSITIONS AND METHODS FOR LIPOMODELING
|
MY152185A
(en)
|
2005-06-10 |
2014-08-29 |
Novartis Ag |
Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation
|
EP1760076A1
(en)
|
2005-09-02 |
2007-03-07 |
Ferring B.V. |
FAP Inhibitors
|
EA015169B1
(en)
|
2005-09-14 |
2011-06-30 |
Такеда Фармасьютикал Компани Лимитед |
Use of dipeptidyl peptidase inhibitors
|
PT1931350E
(en)
*
|
2005-09-14 |
2014-02-12 |
Takeda Pharmaceutical |
Administration of dipeptidyl peptidase inhibitors
|
CN102675221A
(en)
*
|
2005-09-16 |
2012-09-19 |
武田药品工业株式会社 |
Intermediate in method for preparing pyrimidinedione derivative
|
TW200745080A
(en)
*
|
2005-09-16 |
2007-12-16 |
Takeda Pharmaceuticals Co |
Polymorphs of tartrate salt of 2-[2-(3-(R)-amino-piperidin-1-yl)-5-fluoro-6-oxo-6H-pyrimidin-1-ylmethyl]-benzonitrile and methods of use therefor
|
TW200745079A
(en)
*
|
2005-09-16 |
2007-12-16 |
Takeda Pharmaceuticals Co |
Polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor
|
GB0526291D0
(en)
|
2005-12-23 |
2006-02-01 |
Prosidion Ltd |
Therapeutic method
|
JP5101489B2
(en)
*
|
2006-03-08 |
2012-12-19 |
杏林製薬株式会社 |
Process for producing aminoacetylpyrrolidinecarbonitrile derivative and its production intermediate
|
JP2009531456A
(en)
*
|
2006-03-28 |
2009-09-03 |
武田薬品工業株式会社 |
Preparation of (R) -3-aminopiperidine dihydrochloride
|
WO2007112347A1
(en)
|
2006-03-28 |
2007-10-04 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
PE20071221A1
(en)
|
2006-04-11 |
2007-12-14 |
Arena Pharm Inc |
GPR119 RECEPTOR AGONISTS IN METHODS TO INCREASE BONE MASS AND TO TREAT OSTEOPOROSIS AND OTHER CONDITIONS CHARACTERIZED BY LOW BONE MASS, AND COMBINED THERAPY RELATED TO THESE AGONISTS
|
EP1971862B1
(en)
|
2006-04-11 |
2010-11-10 |
Arena Pharmaceuticals, Inc. |
Methods of using gpr119 receptor to identify compounds useful for increasing bone mass in an individual
|
WO2007148185A2
(en)
*
|
2006-06-21 |
2007-12-27 |
Pfizer Products Inc. |
Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors
|
US8324383B2
(en)
|
2006-09-13 |
2012-12-04 |
Takeda Pharmaceutical Company Limited |
Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
|
TW200838536A
(en)
|
2006-11-29 |
2008-10-01 |
Takeda Pharmaceutical |
Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
|
JP2010120851A
(en)
*
|
2007-02-09 |
2010-06-03 |
Kyorin Pharmaceut Co Ltd |
Dimerized cyclo derivative
|
US8093236B2
(en)
|
2007-03-13 |
2012-01-10 |
Takeda Pharmaceuticals Company Limited |
Weekly administration of dipeptidyl peptidase inhibitors
|
WO2008114857A1
(en)
*
|
2007-03-22 |
2008-09-25 |
Kyorin Pharmaceutical Co., Ltd. |
Method for producing aminoacetylpyrrolidinecarbonitrile derivative
|
KR20120030570A
(en)
*
|
2007-04-03 |
2012-03-28 |
미쓰비시 타나베 파마 코퍼레이션 |
Combined use of dipeptidyl peptidase iv inhibitor compound and sweetener
|
GB2465132B
(en)
*
|
2007-09-21 |
2012-06-06 |
Lupin Ltd |
Compounds as dipeptidyl peptidase IV (DPP IV) inhibitors
|
MX2010007593A
(en)
*
|
2008-01-10 |
2010-10-13 |
Sun Pharma Advanced Res Co Ltd |
Novel derivatives of acyl cyanopyrrolidines.
|
CL2008003653A1
(en)
*
|
2008-01-17 |
2010-03-05 |
Mitsubishi Tanabe Pharma Corp |
Use of a glucopyranosyl-derived sglt inhibitor and a selected dppiv inhibitor to treat diabetes; and pharmaceutical composition.
|
US8278313B2
(en)
|
2008-03-11 |
2012-10-02 |
Abbott Laboratories |
Macrocyclic spiro pyrimidine derivatives
|
US8436005B2
(en)
|
2008-04-03 |
2013-05-07 |
Abbott Laboratories |
Macrocyclic pyrimidine derivatives
|
EP2146210A1
(en)
|
2008-04-07 |
2010-01-20 |
Arena Pharmaceuticals, Inc. |
Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY
|
CA2732984A1
(en)
*
|
2008-08-07 |
2010-02-11 |
Kyorin Pharmaceutical Co., Ltd. |
Process for production of bicyclo[2.2.2]octylamine derivative
|
WO2010018866A1
(en)
*
|
2008-08-14 |
2010-02-18 |
杏林製薬株式会社 |
Stabilized pharmaceutical composition
|
WO2010039124A1
(en)
*
|
2008-09-30 |
2010-04-08 |
Mitsubishi Tanabe Pharma Corporation |
Benzenesulfonic acid salt compounds
|
US7965235B2
(en)
*
|
2009-02-24 |
2011-06-21 |
Raytheon Company |
Multi-channel thinned TR module architecture
|
US7876263B2
(en)
*
|
2009-02-24 |
2011-01-25 |
Raytheon Company |
Asymmetrically thinned active array TR module and antenna architecture
|
US8748457B2
(en)
|
2009-06-18 |
2014-06-10 |
Lupin Limited |
2-amino-2- [8-(dimethyl carbamoyl)- 8-aza- bicyclo [3.2.1] oct-3-yl]-exo- ethanoyl derivatives as potent DPP-IV inhibitors
|
AR077642A1
(en)
|
2009-07-09 |
2011-09-14 |
Arena Pharm Inc |
METABOLISM MODULATORS AND THE TREATMENT OF DISORDERS RELATED TO THE SAME
|
EP2556056A1
(en)
|
2010-04-06 |
2013-02-13 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
SG188548A1
(en)
|
2010-09-22 |
2013-04-30 |
Arena Pharm Inc |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
WO2012135570A1
(en)
|
2011-04-01 |
2012-10-04 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
US20140066369A1
(en)
|
2011-04-19 |
2014-03-06 |
Arena Pharmaceuticals, Inc. |
Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
|
WO2012145604A1
(en)
|
2011-04-22 |
2012-10-26 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
WO2012145603A1
(en)
|
2011-04-22 |
2012-10-26 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
WO2012170702A1
(en)
|
2011-06-08 |
2012-12-13 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
EP2729468A4
(en)
*
|
2011-07-05 |
2015-03-18 |
Merck Sharp & Dohme |
Tricyclic heterocycles useful as dipeptidyl peptidase-iv inhibitors
|
WO2013055910A1
(en)
|
2011-10-12 |
2013-04-18 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
CN102875558A
(en)
*
|
2012-11-05 |
2013-01-16 |
贵州大学 |
2-chloro-4-substituted-8-nitrobenzofuran [3,2-d] miazines compound, preparation method of compound and application of compound
|
WO2014074668A1
(en)
|
2012-11-08 |
2014-05-15 |
Arena Pharmaceuticals, Inc. |
Modulators of gpr119 and the treatment of disorders related thereto
|
MY176401A
(en)
|
2014-04-24 |
2020-08-05 |
Mitsubishi Tanabe Pharma Corp |
Novel disubstituted 1,2,4-triazine compound
|
BR112017019170A2
(en)
|
2015-03-09 |
2018-07-10 |
Intekrin Therapeutics, Inc. |
Methods for treating non-alcoholic fatty liver disease and / or lipodystrophy
|
JP2020515639A
(en)
|
2017-04-03 |
2020-05-28 |
コヒラス・バイオサイエンシズ・インコーポレイテッド |
PPARγ agonists for the treatment of progressive supranuclear palsy
|
WO2019154859A1
(en)
*
|
2018-02-06 |
2019-08-15 |
Universität Heidelberg |
Fap inhibitor
|
CN108218865B
(en)
*
|
2018-03-31 |
2020-06-26 |
济南市儿童医院 |
Amide derivative and application thereof in cardiovascular and cerebrovascular aspects
|
CN108456207B
(en)
*
|
2018-03-31 |
2020-11-20 |
浙江药苑生物科技有限公司 |
Amide derivative and application thereof in cardiovascular and cerebrovascular aspects
|
CN114288292B
(en)
*
|
2021-12-10 |
2023-06-13 |
中南大学湘雅医院 |
Application of aromatic compound as activator of nerve Cong Su protein-B2 in preparation of medicine for treating osteoporosis
|
WO2023233024A1
(en)
|
2022-06-03 |
2023-12-07 |
Universiteit Antwerpen |
Dpp9 binding compounds
|